Sort
82,697 grants matching “vaccine development”
Advancing a Glioma Immunotherapy
$981,388Dwaine Franklin Emerich · In Cytu, Inc. · R44 · FY2013 · NS
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever
$981,197Matthias Schnell · Thomas Jefferson University · N01 · FY2023 · AI
Shigella Conjugate Vaccine (SCV4) Development, Characterization, and Pre-clinical Evaluation
$981,139Edward T. Ryan · Massachusetts General Hospital · R01 · FY2024 · AI
Pandemic Influenza Translational Research and novel universal countermeasure development
$981,112Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Identification and validation of influenza host factors as therapeutic targets
$980,999David E Root · Broad Institute, Inc. · U01 · FY2009 · AI
A Randomized Phase I Clinical Trial of HydroVax-CHIKV, a Novel Inactivated Chikungunya Virus Vaccine
$980,963Ian James Amanna · Najit Technologies, Inc. · U44 · FY2025 · AI
NCMHD-Research Center of Excellence at the University of Pittsburgh
$980,936Stephen B. Thomas · University Of Pittsburgh At Pittsburgh · P60 · FY2008 · MD
Cryopreservation of Anopheles Embryos
$980,922Peter F. Billingsley · Sanaria, Inc. · R44 · FY2015 · AI
Defining T cell epitopes in Dengue virus infection
$980,526Ramila Philip · Immunotope, Inc. · R44 · FY2013 · AI
COBRE Phase III: Transitional Center for Research on Processes in Evolution
$980,492Larry J Forney · University Of Idaho · P30 · FY2016 · GM
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$980,283Pablo Tamayo · University Of California, San Diego · U01 · FY2019 · CA
P1 - COMBINATION ACTIVATED T-CELL AND VACCINE THERAPY IN MYELOMA
$980,225Larry W Kwak · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1
$980,219Erol Fikrig · L2 Diagnostics, Llc · R42 · FY2024 · AI
Host Immune Responses to Antigens of Malaria Parasites
$980,178Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Administration
$980,033John R. Murphy · Boston University Medical Campus · UC7 · FY2015 · AI
Clinical Evaluation of Novel Adenovirus Vectors
$979,976Raphael Dolin · Beth Israel Deaconess Medical Center · U19 · FY2008 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$979,886David S Stephens · Emory University · UM1 · FY2020 · AI
Cape Town Clinical Trials Unit (CT-CTU) for HIV/AIDS Prevention & Treatment
$979,642Robin Wood · University Of Cape Town · U01 · FY2007 · AI
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses
$979,627Richard K. Plemper · Georgia State University · R01 · FY2021 · AI
Clinical Development of Combination Plague/Smallpox Vaccine
$979,594Charalambos Partidos · Inviragen, Inc. · R44 · FY2009 · AI
A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1
$979,482Erol Fikrig · L2 Diagnostics, Llc · R42 · FY2023 · AI
IMMUNITY TO STDS IN THE HUMAN MALE GENITAL TRACT
$979,478Brigham And Women'S Hospital · P01 · FY2000 · AI
Development and Manufacture of Adjuvants for Vaccines Targeting MDR Tuberculosis
$979,306Rhea N Coler · Access To Advanced Health Institute · U01 · FY2008 · AI
Task B13: Evaluation of MCMs directed against BSL-4 Viruses in Non-Human Primates (NHPs)
$978,859David Beasley · University Of Texas Med Br Galveston · N01 · FY2021 · AI
SOUTH AFRICA MRC HIV PREVENTION TRIALS UNIT
$978,838Medical Research Council Of South Africa · U01 · FY2002 · AI